This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mink Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Robert Benjamin Stein
Introduction
Robert Benjamin Stein is an accomplished inventor based in Brooklyn, NY. He has made significant contributions to the field of biotechnology, particularly in the development of engineered host cells. His work focuses on enhancing the expression of functional T cell receptors, which are crucial for immune response.
Latest Patents
Stein holds a patent for "Engineered host cells and methods of use thereof." This patent describes engineered host cells that are suitable for the expression of functional T cell receptors (TCRs). The methods outlined in the patent enable the identification of TCRs that specifically bind to desired peptide-major histocompatibility complex (MHC) complexes. This innovation has the potential to advance therapeutic approaches in immunology.
Career Highlights
Stein is currently associated with Mink Therapeutics, Inc., where he continues to push the boundaries of research in engineered cells. His work is pivotal in the development of new therapies that harness the power of the immune system.
Collaborations
Stein collaborates with notable professionals in his field, including Marc Van Dijk and Volker Seibert. These partnerships enhance the research and development efforts at Mink Therapeutics, Inc.
Conclusion
Robert Benjamin Stein's contributions to biotechnology through his innovative patent and collaborative efforts position him as a key figure in the advancement of immunological therapies. His work exemplifies the impact of engineering in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile